Group One Trading
COGT icon

Group One Trading’s Cogent Biosciences COGT Stock Holding History

Group One Trading’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50,505
Closed -$1.42M – 8254
2025
Q3 		$725K Sell
50,505
-21,939
-30% -$260K ﹤0.01% 3326
2025
Q2 		$520K Buy
72,444
+71,784
+10,876% +$398K ﹤0.01% 3384
2025
Q1 		$3.95K Buy
+660
New +$5.17K ﹤0.01% 6738
2024
Q4 		– Sell
-4,856
Closed -$48.4K – 7359
2024
Q3 		$52.4K Buy
4,856
+960
+25% +$9.35K ﹤0.01% 4630
2024
Q2 		$32.8K Buy
3,896
+3,810
+4,430% +$28.9K ﹤0.01% 4847
2024
Q1 		$578 Buy
+86
New +$532 ﹤0.01% 6719
2023
Q2 		– Sell
-26
Closed -$298 – 7713
2023
Q1 		$281 Sell
26
-1,549
-98% -$19.8K ﹤0.01% 6969
2022
Q4 		$18.2K Buy
1,575
+434
+38% +$5.38K ﹤0.01% 5653
2022
Q3 		$17K Sell
1,141
-3,459
-75% -$47.4K ﹤0.01% 6168
2022
Q2 		$41K Buy
+4,600
New +$31.4K ﹤0.01% 5719

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Group One Trading's COGT Position: Q4 2025 in Review

Group One Trading sold out of Cogent Biosciences (COGT) in Q4 2025, closing a stake of 50,505 shares — an estimated $1.42M sold.

Group One Trading first reported a position in COGT in Q2 2022 and held it in 10 quarters. The position peaked at $725K in Q3 2025. 267 funds tracked by Wall St. Rank hold COGT as of Q4 2025.

  • Group One Trading reported no remaining Cogent Biosciences position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 50,505 Cogent Biosciences shares in Q4 2025, an estimated $1.42M.
  • Group One Trading first reported a position in Cogent Biosciences in Q2 2022 and held it in 10 quarters.
  • Group One Trading's Cogent Biosciences position peaked at $725K in Q3 2025.
  • 267 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.